Ibandronate Sodium Tablet
Product Images NDC 69452-378

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ibandronate Sodium (NDC 69452-378). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bionpharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton)

The packaging label for Ibandronate Sodium Tablets 150 mg oral tablets by Bionpharma Inc. The label indicates a 3 film-coated tablets blister pack, intended for once-monthly use, with a three-month supply. It includes dosing and storage instructions, the NDC 69452-378-74, and a barcode. The label is primarily white with green and purple accents.*

FDA Label Image

Structure (Structure)

Chemical structure of ibandronate sodium depicting the molecular arrangement including phosphate groups, hydroxyl groups, a sodium ion, and a hydrocarbon chain with a methyl-substituted nitrogen.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.